Beroni USA is Ready to Commercialise a Diagnostic Kit for Detecting Zika, Dengue, Chikungunya and West Nile Viruses Worldwide

NEXT STORY
Veyonda® and Radiotherapy Profiled at Key Oncology Meeting
PREV STORY
INmune Bio Invited to Speak on Company’s Advancements in Cancer Treatments at the Targeting Innate Immunity Congress and MarketsandMarkets Next Gen Immuno-Oncology Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Auris Medical on Track to Resume Enrollment of Keyzilen Tinnitus Program Following Regulatory Feedback

TACTT3 Phase 3 trial to resume enrollment in early 2017 as previously announcedZUG, Switzerland, ...

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Presents Update from Ongoing Phase 1 Dose Escalation Clinical Trial of Intratumoral IMO-2125 in Combination with Ipilimumab in Metastatic Melanoma Patients Refractory to Anti-PD-1 Treatment at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium

ORLANDO, Fla., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage ...

author_avatar
NASDAQ Market News

Oxford Biomedica plc Preliminary results for the year ended 31 December 2020

author_avatar
NASDAQ Market News